EUVIMEDEUVIMED entdecken
Open Access

Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR patterns of care study

Rosemary D Cress, Susan A Sabatino, Xiao-Cheng Wu, Maria J Schymura, Randi Rycroft, Erik Stuckart, John Fulton, Tiefu Shen

Clinical medicine. Oncology · 2009

DOI: 10.4137/cmo.s2316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical medicine. Oncology, 2009. Verfasst von Rosemary D Cress und 7 weiteren Autor:innen. Beteiligte Einrichtung: California Cancer Registry, Public Health Institute, Department of Public Health Sciences, Division of Epidemiology, University of California Davis, …. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate adjuvant chemotherapy use for Stage III colon cancer.

Methods

This analysis included 973 patients with surgically treated stage III colon cancer. Socioeconomic information from the 2000 census was linked to patients’ residential census tracts. Vital status through 12/31/02 was obtained from medical records and linkage to state vital statistics files and the National Death Index.

Results

Adjuvant chemotherapy was received by 67%. Treatment varied by state of residence, with Colorado, Rhode Island and New York residents more likely to receive chemotherapy than Louisiana residents. Older age, increasing comorbidities, divorced/widowed marital status, and residence in lower education areas or non-working class neighborhoods were associated with lower chemotherapy use. Survival varied by state but after adjustment for sex, sociodemographic and health factors, was significantly higher only for California and Rhode Island. Older age and lower educational attainment were associated with lower survival. Chemotherapy was protective for all comorbidity groups.

Conclusion

Although adjuvant chemotherapy for Stage III colon cancer improves survival, some patients did not receive standard of care, demonstrating the need for cancer treatment surveillance. Interstate differences likely resulted from differences in local practice patterns, acceptance of treatment, and access.

Schlagwörter

Stichwörter der Autor:innen

adjuvant chemotherapycolorectal cancerpatterns of care

Autor:innen und Institutionen

  • California Cancer Registry, Public Health Institute, Department of Public Health Sciences, Division of Epidemiology, University of California Davis, Sacramento, CA, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Cress, R. D., Sabatino, S. A., Wu, X. C., Schymura, M. J., Rycroft, R., Stuckart, E., Fulton, J., & Shen, T. (2009). Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR patterns of care study. Clinical medicine. Oncology. https://doi.org/10.4137/cmo.s2316

Vancouver

Cress RD, Sabatino SA, Wu XC, Schymura MJ, Rycroft R, Stuckart E, et al. Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR patterns of care study. Clinical medicine. Oncology. 2009. doi:10.4137/cmo.s2316

BibTeX
@article{Cress2009,
  author = {Cress, Rosemary D and Sabatino, Susan A and Wu, Xiao-Cheng and Schymura, Maria J and Rycroft, Randi and Stuckart, Erik and Fulton, John and Shen, Tiefu},
  title = {Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR patterns of care study},
  journal = {Clinical medicine. Oncology},
  year = {2009},
  doi = {10.4137/cmo.s2316}
}
Kostenlos starten →